top of page

Income Tax (Deduction for Investment in a BioNexus Status Company) (Amendment) Rules 2024

  • Writer: CCS
    CCS
  • Jan 30, 2024
  • 1 min read

The Income Tax (Deduction for Investment in a BioNexus Status Company) (Amendment) Rules 2024 [P.U. (A) 23/2023] are deemed to have come into operation on 1 January 2023.


The changes made to the specific provisions in the amendment rules involve updating the commencement and termination dates for the deduction for investment in a BioNexus status company.


The amendments include:

  1. Substituting the previous commencement date of "1 January 2021" with a new commencement date of "1 January 2023".

  2. Substituting the previous termination date of "31 December 2022" with a new termination date of "31 December 2024".

References:

Income Tax (Deduction for Investment in a BioNexus Status Company) (Amendment) Rules 2024


Income Tax (Deduction for Investment in a BioNexus Status Company) Rules 2016 [P.U. (A) 306/2016]


Comments


CCS & CO PLT 202206000043 (LLP0033899-LCA) & AF 1538 was registered on 29th December 2022. With effect from that date, CCS & CO (AF 1538), a conventional partnership, was converted to a limited liability partnership.

©2019 - 2023 by CCS . All rights reserved.

bottom of page